The Food and Drug Administration established a Blanket Purchase Agreement with AB Sciex LLC on September 25, 2026, with a $9.5 million ceiling, against the GSA Multiple Award Schedule for SCIEX liquid chromatography-mass spectrometer systems, including triple quadrupole instruments, UHPLC platforms, HPLC systems, diode array detectors, and nitrogen generators.
The BPA incorporates non-GSA (open market) items totaling $3.135 million, including UHPLC bundles from Shimadzu and Agilent, software licenses, training courses, computer workstations, infrastructure items such as uninterruptible power supplies and network equipment, and installation and calibration services. Non-Schedule components exceeding $20,000 are incorporated as individual open-market line items with mandatory commercial contract clauses. The Contracting Officer verified price reasonableness before final BPA execution.
The BPA covers PSC 6640 and NAICS 334516. Performance period runs through September 24, 2030.